These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34738481)

  • 1. Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report.
    Xu J; Feng Q; Chen Y; Liu XL; Jiang O
    J Int Med Res; 2021 Nov; 49(11):3000605211055387. PubMed ID: 34738481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Long-Term Remission with Surgical Therapy and Chemoradiotherapy for a Rapidly Increasing Large Cell Neuroendocrine Carcinoma(LCNEC)].
    Yasuda K; Kashu N; Mushiake Y; Takami T; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):257-260. PubMed ID: 36807190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.
    Rossi G; Cavazza A; Marchioni A; Longo L; Migaldi M; Sartori G; Bigiani N; Schirosi L; Casali C; Morandi U; Facciolongo N; Maiorana A; Bavieri M; Fabbri LM; Brambilla E
    J Clin Oncol; 2005 Dec; 23(34):8774-85. PubMed ID: 16314638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab.
    Oda R; Okuda K; Yamashita Y; Sakane T; Tatematsu T; Yokota K; Endo K; Nakanishi R
    Thorac Cancer; 2020 Jul; 11(7):2036-2039. PubMed ID: 32379390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lung large cell neuroendocrine carcinoma.
    Lo Russo G; Pusceddu S; Proto C; Macerelli M; Signorelli D; Vitali M; Ganzinelli M; Gallucci R; Zilembo N; Platania M; Buzzoni R; de Braud F; Garassino MC
    Tumour Biol; 2016 Jun; 37(6):7047-57. PubMed ID: 26943800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study of advanced large cell neuroendocrine carcinoma].
    Kishi K; Homma S; Takaya H; Miyamoto A; Sakamoto S; Kurosaki A; Motoi N; Yoshimura K
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):556-60. PubMed ID: 16972612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
    Honma Y; Nagashima K; Hirano H; Shoji H; Iwasa S; Takashima A; Okita N; Kato K; Boku N; Murakami N; Inaba K; Ito Y; Itami J; Kanamori J; Oguma J; Daiko H
    Cancer Med; 2020 Jan; 9(2):595-604. PubMed ID: 31794158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report.
    Wei J; Dong XF; Hu ZL; Tang S; Lu YF
    Medicine (Baltimore); 2018 Dec; 97(51):e13318. PubMed ID: 30572435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches.
    Khan J; Yasinzai AQK; Matosz S; Khan M; Heneidi S; Mesa H; Chauhan A; Del Rivero J; Karim NA; Ullah A
    Clin Exp Med; 2023 Nov; 23(7):3947-3955. PubMed ID: 37060529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
    Vrontis K; Economidou SC; Fotopoulos G
    Cancer Invest; 2022 Feb; 40(2):124-131. PubMed ID: 34601985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
    Tangjitgamol S; Manusirivithaya S; Choomchuay N; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P
    J Obstet Gynaecol Res; 2007 Apr; 33(2):218-24. PubMed ID: 17441901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

  • 16. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
    Kozuki T; Fujimoto N; Ueoka H; Kiura K; Fujiwara K; Shiomi K; Mizobuchi K; Tabata M; Hamazaki S; Tanimoto M
    J Cancer Res Clin Oncol; 2005 Mar; 131(3):147-51. PubMed ID: 15538626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
    Abedallaa N; Tremblay L; Baey C; Fabre D; Planchard D; Pignon JP; Guigay J; Pechoux CL; Soria JC; de Montpreville VT; Besse B
    J Thorac Oncol; 2012 Jul; 7(7):1179-83. PubMed ID: 22617247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An elderly patient with large cell neuroendocrine carcinoma(LCNEC)for whom chemotherapy with irinotecan and split-dose cisplatin(CDDP)proved very effective].
    Tanno S; Onodera H; Inoue S; Honda R; Nagashima K; Ohsaki Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1205-8. PubMed ID: 24047780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
    Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
    Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy.
    Hidaka T; Okuzumi S; Matsuhashi A; Takahashi H; Hata K; Shimizu S; Iwasaki Y
    Intern Med; 2019 Feb; 58(4):563-568. PubMed ID: 30333385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.